HSP90/mTOR-IN-1
HSP90/mTOR-IN-1 is a potent and orally active Hsp90 and mTOR inhibitor with IC50 values of 69 nM and 29 nM, respectively. HSP90/mTOR-IN-1 suppresses the proliferation of SW780 cells through the over-activation of the PI3K/AKT/mTOR pathway. HSP90/mTOR-IN-1 induces apoptosis and autophagy via selective Hsp90 and mTOR inhibition. HSP90/mTOR-IN-1 also has considerable in vivo anti-tumor activity. HSP90/mTOR-IN-1 can be used for researching bladder cancer.
For research use only. We do not sell to patients.
- CAS No.: 3033543-67-5
- Formula: C36H34ClFN6O5S
- Molecular Weight:717.21
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
mTOR 29 nM (IC50) |
HSP90 69 nM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| J82 | IC50 |
0.36 μM
Compound: 17o
|
Antiproliferative activity against human J82 cells assessed as inhibition of cell proliferation by CCK8 assay
Antiproliferative activity against human J82 cells assessed as inhibition of cell proliferation by CCK8 assay
|
[PMID: 35987020] |
| SW780 | IC50 |
0.16 μM
Compound: 17o
|
Antiproliferative activity against human SW780 cells assessed as inhibition of cell proliferation by CCK8 assay
Antiproliferative activity against human SW780 cells assessed as inhibition of cell proliferation by CCK8 assay
|
[PMID: 35987020] |
| T-24 | IC50 |
0.41 μM
Compound: 17o
|
Antiproliferative activity against human T24 cells assessed as inhibition of cell proliferation by CCK8 assay
Antiproliferative activity against human T24 cells assessed as inhibition of cell proliferation by CCK8 assay
|
[PMID: 35987020] |
HSP90/mTOR-IN-1 (compound 17o) has antiproliferative activity against J82, T24 and SW780 cells[1].
HSP90/mTOR-IN-1 (0.2 and 0.5 μM; 24 h) induces SW870 apoptosis in a dose-dependent manner, induces the formation of autophagosome[1].
HSP90/mTOR-IN-1 (0.2 and 0.5 μM; 24 h) decreases the expression of several Hsp90 client proteins in SW870[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:J82, T24 and SW780[1]
-
Concentration:0-1 μM
-
Incubation Time:48 h
-
Result:Exhibited antiproliferative activity against J82, T24 and SW780 with IC50s of 0.36 ± 0.03 μM, 0.41 ± 0.06 μM, 0.16 ± 0.03 μM.
-
Cell Line:SW870
-
Concentration:0.2 and 0.5 μM
-
Incubation Time:24 h
-
Result:Induced apoptosis in a dose-dependent manner (total apoptotic cell percentage was 12.4% and 16.5% at 0.2 and 0.5 μM, respectively).
-
Cell Line:SW870 (transfected with GFP-LC3)
-
Concentration:0.2 and 0.5 μM
-
Incubation Time:24 h
-
Result:Induced the formation of autophagosome.
The green fluorescent spots were observed to increase in the number and gathered.
-
Cell Line:SW870
-
Concentration:0.2 and 0.5 μM
-
Incubation Time:24 h
-
Result:Significantly decreased the expression of several Hsp90 client proteins, CDK4, C-Raf and CDC2.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Balc/c nude mice (6-8 weeks; subcutaneously injected with 1×106 cells per 100 μL of J82 cells into the mice's dorsal skin)[1]
-
Dosage:30 mg/kg
-
Administration:PO; for 17 days
-
Result:Exhibited significantly superior tumor growth inhibition, and did not showed remarkable weight decline.
Inhibited bladder cancer cell proliferation, induced cell apoptosis, degraded Hsp70, as well as decreased phosphorylation levels of mTOR and increased expression of LC3-II.
Chemical Information
-
CAS No. 3033543-67-5
-
Molecular Weight 717.21
-
Formula C36H34ClFN6O5S
-
SMILES
ClC1=CC(NC(NC2=CC=C(C=C2)C3=NC(N4CCOCC4)=C5C6=C(SC5=N3)CN(CC6)C(C7=CC(C(C)C)=C(C=C7O)O)=O)=O)=CC=C1F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)